Aspen Pharmacare Holdings Limited (JSE: APN)
Health Care · Pharmaceuticals · ZA
R158.26
-1.09% today · +60.0% 1Y
Aspen Pharmacare Holdings Limited (JSE: APN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.25B and employs 9,343 people.
Over the last twelve months the share price has gained 60.0%, trading between 90.70 and 166.21.
Tweenvest scores Aspen Pharmacare Holdings Limited across four factors: quality 72/100, value 43/100, growth 12/100, dividend 55/100. Its strongest factor is quality.
APN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.25B
- Revenue (TTM)
- $2.13B
- P/E
- —
- EPS
- 5.96
- Dividend yield
- 1.47%
- Beta (5Y)
- 0.52
- 52-week high
- R166.21
- 52-week low
- R90.70
- Avg volume (3M)
- —
- Shares outstanding
- 444.02M
- Employees
- 9,343
- Next earnings
- —
About Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceutical ingredients and finished dose form products for other companies. Established in 1850, the company's headquarters are located in Durban, South Africa.
- ISIN
- ZAE000066692
- Founded
- 1850
- Listed since
- Nov 27, 1998
- Exchange
- The Johannesburg Securities Exchange
- Currency
- ZAR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ajanta Pharma LimitedNSEI: AJANTPHARM | $4.40B | Rs3,410.10 | -4.77% |
| Dottikon ES Holding AGSWX: DESN | $4.32B | CHF260.00 | +1.36% |
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.31B | CN¥71.90 | +3.86% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.27B | CN¥25.40 | -8.44% |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.24B | $39.06 | -0.43% |
| Sam Chun Dang Pharm. Co., LtdKOSDAQ: A000250 | $4.24B | ₩243,500.00 | +17.63% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.23B | ₩72,700.00 | -4.09% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.23B | $35.83 | +1.07% |
Figures last refreshed Oct 11, 2026.